On August 14, 2026, HeartBeam, Inc. (the "Company"), entered into an At-The-Market Equity Offering Sales Agreement (the "Sales Agreement") with Titan Partners Securities LLC, as sales agent, pursuant to which the Company may sell, from time to time, an aggregate of up to $25,000,000 of its common stock, par value $0.0001 per share (the "Shares").

 

The Shares may be issued and sold from time to time through the sales agent pursuant to the Company’s shelf Registration Statement on Form S-3 (Reg. No. 333-293307). The Company has filed a prospectus supplement, dated August 14, 2026, pursuant to Rule 424(b) under the Securities Act of 1933, as amended, with respect to the Shares.

 

Sales of the Shares, if any, under this prospectus supplement may be made in transactions that are deemed to be "at the market offerings" pursuant to Rule 415 under the Securities Act of 1933, as amended, including by means of ordinary brokers’ transactions on the Nasdaq Capital Market at market prices, in block transactions, or as otherwise agreed upon by the sales agent and the Company.

 

The Company will pay the sales agent a commission of up to 3% of the gross sales price per share for any Shares sold through such sales agent under the Sales Agreement. The Company has provided the sales agent with customary indemnification and contribution rights.